Is FEMY Worth Buying in 2026?

Femasys Inc. Common Stock

STOCK SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Updated 2026-05-24

Here’s whether Femasys Inc. Common Stock (FEMY) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: above the 50-day MA (medium-term momentum positive); RSI 60 — healthy momentum range. Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-7.18% over 10 days); weak 1-year return of -58.7%; 3-month momentum negative (-19.6%); rising volume on a downtrend (distribution, 2.13x avg). Currently 60.5% off its 52-week high. Score: -3/7.

Ready to act on this? 📈 Trade on Webull

FEMY is trading below its 200-day MA ($0.58) — a key warning sign the longer-term trend is under pressure. An RSI of 60.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -58.7% compares to +27.9% for SPY (trailed the market by 86.6%). The current 60.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $4,132 today
vs. S&P 500 (SPY) — same period trailed market by 86.6%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($0.58)
Above 50-day MA ($0.43)
RSI(14) neutral zone (30–70) — currently 60.4
Positive return (-58.7%)
!Within 10% of period high (−60.5%)
Period Range $0.44
$0.31 $1.11
RSI (14) 60.4
0 · OversoldOverbought · 100

Key Metrics

Price$0.44
Period Return-58.7%
Period High$1.11
Period Low$0.31
Drawdown−60.5%
MA-50$0.43
MA-200$0.58
RSI (14)60.4
Avg Volume (30d)947K
vs. SPYtrailed by 86.6%
Return Rank#1126 of 1236

Trade FEMY

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers